This federal contract award, valued at $17,760.00, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of Mirena 52 mg systems, a contraceptive device, with an ultimate completion date of October 17, 2024.
DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical items to support the medical supply needs of the Department of Defense healthcare facilities worldwide. The contract does not have a set-aside designation.
Generated 12/25/24, 9:19 AM